Treatment of hepatocellular carcinoma in patients with cirrhosis

Journal of Hepatology

Volumn 27, Issue 4, 1997, Pages 756-765

  Trinchet, Jean Claude ^a   Beaugrand, Michel ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIANDROGEN; DOXORUBICIN; IODINATED POPPYSEED OIL; TAMOXIFEN;

ARTIFICIAL EMBOLISM; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT PLANNING;

EID: 0030842686     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80095-5     Document Type: Review

References (114)

1. Colombo M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis. 13:1993;374-383.
2. Khakoo SI, Grellier LFL, Soni PN, Bhattacharya S, Dusheiko GM. Etiology, screening, and treatment of hepatocellular carcinoma. Med Clin North Am. 80:1996;1121-1145.
3. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:1985;918-928.
4. Calvet X, Bruix J, Bru C, Gines P, Vilana R, Sole M, et al. Natural history of hepatocellular carcinoma. Five year's experience in 249 cases. J Hepatol. 10:1990;311-317.
5. Calvet X, Briux J, Gines P, Bru C, Sole M, Vilana R, et al. Prognostic factors of hepatocellular carcinoma in the West. A multivariate analysis in 206 patients. Hepatology. 12:1990;753-760.
6. Attali P, Prod'homme S, Pelletier G, Papoz L, Ink O, Buffet C, et al. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer. 59:1987;2108-2111.
7. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 54:1984;1461-1465.
8. Ohnishi K, Tanabe Y, Ryu M, Isono K, Yamamoto Y, Usui S, et al. Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment. Study of 100 patients. Hepatology. 7:1987;1285-1290.
9. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res. 48:1988;7314-7318.
10. Okuda K, Peters R, Simson I. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer. 54:1984;2165-2173.
11. Lai C, Wu P, Chan G, Lok A, Lin H. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. Cancer. 62:1988;479-483.
12. Lai CL, Lau JYN, Wu PC, Ngan H, Chung HT, Mitchell SJ, et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma. A randomized controlled trial. Hepatology. 17:1993;389-394.
13. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med. 35:1994;1782-1787.
14. Triller J, Baer HU, Geiger L, Kinser J, Rosler H, Blumgart LH. Radioembolisation of hepatocellular carcinoma with 90-yttrium resin particles. Eur Radiol. 5:1995;603-608.
15. Manesis EK, Giannoulis G, Zoumbolis P, Vafiadou I, Hadziyannis SJ. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatoloty. 21:1995;1535-1542.
16. Sato M, Watanabe Y, Ueda S, Iseki S, Abe Y, Sato N, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology. 110:1996;1507-1514.
17. Kuriyama S, Nakatani T, Masui K, Sakamoto T, Tominaga K, Yoshikawa M, et al. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology. 22:1995;1838-1846.
18. Yokoyama I, Carr B, Saitsu H, Iwatzuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer. 68:1991;2095-2100.
19. Gores G, Steers J. Progress in orthotopic liver transplantation for hepatocellular carcinoma. Gastroenterology. 104:1993;317-320.
20. Gores GJ. Liver transplantation for malignant disease. Gastroenterol Clin North Am. 22:1993;285-299.
21. Iwatsuki S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol. 9:1993;337-340.
22. Bismuth H, Chiche L. Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol. 9:1993;341-345.
23. Ringe B, Pichlmayr R, Wittkind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 15:1991;270-285.
24. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 20:1994;S33-S40.
25. McPeake JR, O'Grady JG, Zaman S, Portmann B, Wright DGD, Tan KC, et al. Liver transplantation for primary hepatocellular carcinoma. Tumor size and number determine outcome. J Hepatol. 18:1993;226-234.
26. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:1996;693-699.
27. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 218:1993;145-151.
28. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients. A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 18:1993;1121-1126.
29. Samuel D, Bismuth H. Liver transplantation for hepatitis-B. Gastroenterol Clin North Ann. 22:1993;271-283.
30. Wright TL. Liver transplantation for chronic hepatitis-C viral infection. Gastroenterol Clin North Am. 22:1993;231-242.
31. Taourel PG, Pageaux GP, Coste V, Fabre JM, Pradel JA, Ramos J, et al. Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil. Radiology. 197:1995;377-380.
32. Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P, et al. Adjuvant chemotherapy improves survival aftr liver transplantation for hepatocellular carcinoma. Ann Surg. 221:1995;734-743.
33. Cherqui D, Piedbois P, Pierga JY, Duvoux C, Vavasseur D, Vannhieu JT, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer. 73:1994;2721-2726.
34. Masutani S, Sasaki Y, Imaoka S, Iwamoto S, Ohashi I, Kameyama M, et al. The prognostic significance of surgica margin in liver resection of patients with hepatocellular carcinoma. Arch Surg. 129:1994;1025-1030.
35. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 106:1994;720-727.
36. Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ, Peng FK. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function. Surgery. 12:1996;34-39.
37. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garciapagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 111:1996;1018-1022.
38. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 108:1995;768-775.
39. Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 129:1994;738-742.
40. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 25:1997;87-92.
41. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 131:1996;71-76.
42. Lee CS, Sheu JC, Wang M, Hsu HC. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg. 83:1996;330-333.
43. Nagashima I, Hamada C, Naruse K, Osada T, Nagao TY, Kawano N, et al. Surgical resection for small hepatocellular carcinoma. Surgery. 119:1996;40-45.
44. Balsells J, Charo R, Lazaro JL, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 83:1996;758-761.
45. Belghiti J, Panis Y, Farges O, Benhamou J, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 214:1991;114-117.
46. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 105:1993;488-494.
47. Nagasue N, Kohno H, Chang YC, Yamanoi A, Kimoto T, Takemoto Y, et al. DNA ploidy pattern in synchronous and metachronous hepatocellular carcinomas. J Hepatol. 16:1992;208-214.
48. Chen PJ, Chen DS, Lai MY, Chang MH, Huang GT, Yang PM, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 96:1989;527-529.
49. Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology. 111:1996;1587-1592.
50. Tang ZY, Yu YQ, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol. 9:1993;293-297.
51. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer. 74:1994;2772-2780.
52. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology. 96:1989;1566-1571.
53. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, et al. Treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol. 22:1995;522-526.
54. Bruix J, Cirera I, Calvet X, Fuster J, Bru C, Ayuso C, et al. Surgical resection and survival in Western patients with hepatocellular carcinoma. J Hepatol. 15:1992;350-355.
55. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 217:1993;375-384.
56. Pitre J, Houssin D, Kracht M. Resection of hepatocellular carcinoma. A multicenter study of 153 patients. Gastroenterol Clin Biol. 17:1993;200-206.
57. Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O, et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology. 20:1994;295-301.
58. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, Peng FK. Preoperative transcathether arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 82:1995;122-126.
59. Yamamoto M, Arii S, Sugahara K, Tobe T. Adjuvant oral chemotherapy to present recurrence after curative resection for hepatocellular carcinoma. Br J Surg. 83:1996;336-340.
60. Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg M, et al. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. Am J Roentgenol. 164:1995;215-220.
61. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Precutaneous ethanol injection therapy for hepatocellular carcinoma. Results in 146 patients. Am J Roentgenol. 160:1993;1023-1028.
62. Vilana R, Bruix J, Bru C, Ayuso c, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology. 16:1992;353-357.
63. Ebara M, Kita K, Sugiura N, Yoshikawa M, Fukuda H, Ohto M, et al. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology. 195:1995;371-377.
64. Sironi S, Decobelli F, Livraghi T, Villa G, Zanello A, Taccgani G, et al. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium enhanced MR imaging follow-up. Radiology. 192:1994;407-412.
65. Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia Em. Treatment of hepatocellular carcinoma with percutaneous ethanol injection. Evaluation with contrast enhanced MR imaging. Am J Roentegenol. 162:1994;827-831.
66. Livraghi T, Giorgio A, Martin G, Salmi A, Desio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1997:1995;101-108.
67. Giorgio A, Tarantino L, Francica G, Mariniello N, Nuzzo A, Delviscovo L, et al. One-shot percutaneuos ethanol injection of liver tumors under general anesthesia: preliminary data on efficacy and complications. Cardiovasc Interv Radiol. 19:1996;27-31.
68. Livraghi T, Lazzaroni S, Pellicano S, Ravasi S, Torzilli G, Vettori C. Percutaneous ethanol injection of hepatic tumors. Single-session therapy with general anesthesia. Am J Roentgenol. 161:1993;1065-1069.
69. Okada S, Aoki K, Okazaki N, Nose H, Yoshimori M, Shimada K, et al. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report. Hepatogastroenterology. 40:1993;496-498.
70. Lencioni R, Bartolozzi C, Carmella D, Paolicchi A, Carrai M, Maltini G, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 western patients. Cancer. 76:1995;1737-1746.
71. Isobe H, Sakai H, Imari Y, Ikeda M, Shiomichi S, Nawata H. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. A study of 37 patients. J Clin Gastroenterol. 18:1994;122-126.
72. Lencioni R, Bartolozzi C, Caramella D, Dicoscio G. Management of adenomatous hyperplastic nodules in the cirrhotic liver. US follow-up or percutaneous alcohol ablation. Abdom Imaging. 18:1993;50-55.
73. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol. 89:1994;194-198.
74. Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer. 78:1996;977-985.
75. Bhattacharya S, Davidson B, Dhillon AP. Blood supply of early hepatocellular carcinoma. Semin Liver Dis. 15:1995;390-401.
76. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma. Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology. 163:1987;345-351.
77. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 163:1992;387-394.
78. Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Interv Radiol. 13:1990;135-139.
79. Stuart K, Stokes K, Jenkins R, Trey C, Clouse M. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 72:1993;3202-3209.
80. Jovine E, Mazziotti A, Grandi U, Iribarren-diaz M, Leo P, Grandolfi L, et al. Abscess formation after chemoembolization of a hepatocellular carcinoma. Hepatogastroenterology. 39:1992;277-281.
81. Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy. Relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol. 88:1993;1410-1415.
82. Khan KN, Nakata K, Shima M, Kusumoto Y, Ishii N, Koji T, et al. Pancreatic tissue damage by transcatheter arterial embolization for hepatoma. Dig Dis Sci. 38:1993;65-70.
83. Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Gastroenterol. 83:1988;837-840.
84. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 148:1983;397-401.
85. Pelletier G, Roche A, Ink O, Anciaux M, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 11:1990;181-184.
86. Groupe d'Etude et de Traitement du Carcinoma Hépatocellulaire. Comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
87. Pelletier G, Ducreux M, Broseta V, Hagège H, Dao T, Van Steenbergen V, et al. Groupe CHC 2. Essai randomisé de la chimioembolisation lipiodolée (CEL) dans le traitement du carcinome hépatocellulaire (CHC) non résécable (abstract). Gastroenterol Clin Biol. 20:1996;A182.
88. Goseki N, Nosaka T, Endo M, Koike M. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolization. Cancer. 76:1995;736-742.
89. Yamashita Y, Torashima M, Oguni T, Yamamoto A, Harada M, Miyazaki T, et al. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma. CT evaluation. Abdom Imaging. 18:1993;352-356.
90. Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma. CT and pathologic findings. Radiology. 182:1992;709-713.
91. Nakamura H, Liu T, Hori S, Mitani H, Murakami T, Kozuka T, et al. Response to transcatheter oily chemoembolization in hepatocellular carcinoma 3-cm or less. A study in 50 patients who underwent surgery. Hepatogastroenterology. 40:1993;6-9.
92. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology. 192:1994;678-690.
93. Bronowicki JP, Boudjema K, Chone L, Nisand G, Bazin C, Pflumio F, et al. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol. 24:1996;293-300.
94. Lai E, Choi TK, Tong SW, Ong GB, Wong J. Treatment of unresectable hepatocellular carcinoma. Results of a randomized controlled trial. World J Surg. 10:1986;51-509.
95. Bruix J, Castells A, Montanya X, Calvet X, Bru C, Ayuso C, et al. Phase II study of transarterial embolization in European patients who hepatocellular carcinoma: need for controlled trials. Hepatology. 20:1994;643-650.
96. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer. 74:1994;2449-2453.
97. Lin D, Liaw Y, Lee T, Lai C. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial. Gastroenterology. 94:1988;453-456.
98. Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg. 82:1995;542-547.
99. Boix L, Bruix J, Castells A, Fuster J, Bru C, Visa J, et al. Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment? J Hepatol. 17:1993;187-191.
100. Carr BI, Van Thiel DH. Hormonal manipulation of human hepatocellular carcinoma. A clinical investigative and therapeutic opportunity. J Hepatol. 11:1990;287-298.
101. Farinati F, Demaria N, Fornasiero A, Salvagini M, Fagiuoli S, Chiaramonte M, et al. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Dig Dis Sci. 37:1992;659-662.
102. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology. 109:1995;917-922.
103. Coll S, Sola R, Vila MC, Andreu M, Bory F, Vasquez D, et al. Treatment with tamoxifen in patients with advanced hepatocellular carcinoma. Results a randomized placebo controlled trial (abstract). Hepatology. 22:1995;404A.
104. Elba S, Giannuzzi V, Misciagna G, Manghisi OG. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma. Ital J Gastroenterol. 26:1994;66-68.
105. Martinez-Cerezo FJ, Tomas A, Donoso L, Enriquez J, Guarner C, Balanzo J, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol. 20:1994;702-706.
106. Villa E, Camellini L, Dugani A, Zucchi F, Grottola A, Merighi A, et al. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res. 55:1995;498-500.
107. Jiang SY, Shyu RY, Yeh MY, Jordan VC. Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism. J Hepatol. 23:1995;712-719.
108. Colombo M. Hepatocellular carcinoma. J Hepatol. 15:1992;225-236.
109. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology. 23:1996;1112-1118.
110. Colombo M, De Franchis R, Del Ninno S, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
111. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in caucasian patients with cirrhosis. J Hepatol. 20:1994;65-71.
112. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med. 101:1996;422-434.
113. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 346:1995;1051-1055.
114. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med. 334:1996;1561-1567.